You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

UCB-J

Showing 1 - 25 of 752
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.

Not yet recruiting
  • Huntington Disease
  • [11C]UCB-J
  • [18F]SynVest-1
  • Leuven, Belgium
    UZ Leuven
Nov 2, 2022

Aberrant Synaptic Plasticity in Cocaine Use Disorder: A

Recruiting
  • Cocaine Use Disorder
  • Healthy Controls
  • 11C-UCB-J
  • New Haven, Connecticut
    Connecticut Mental Health Center
Aug 10, 2022

Opiate Dependence, Cocaine Dependence Trial in New Haven (11UCB-J PET Scan)

Recruiting
  • Opiate Dependence
  • Cocaine Dependence
  • 11UCB-J PET Scan
  • New Haven, Connecticut
    CT Mental Health Center
May 20, 2022

Alzheimer Trial in Lille, Paris, Rouen ([11C]-UCB-J, [18F]-DPA-714, [18F]-RO-948)

Not yet recruiting
  • Alzheimer Disease
  • [11C]-UCB-J
  • +3 more
  • Lille, France
  • +2 more
Jun 12, 2023

Cannabis Use Trial in New Haven ([11C]UCB-J PET)

Recruiting
  • Cannabis Use
  • [11C]UCB-J PET
  • New Haven, Connecticut
    Connecticut Mental Health Center
Aug 17, 2022

Alzheimer Trial in Madison (UCB-J)

Recruiting
  • Alzheimer Disease
  • UCB-J
  • Madison, Wisconsin
    University of Wisconsin
Apr 27, 2022

Huntington Disease Trial in Leuven (11C-UCB-J PET-CT, 18F-FDG PET-MR)

Active, not recruiting
  • Huntington Disease
  • 11C-UCB-J PET-CT
  • 18F-FDG PET-MR
  • Leuven, Vlaams-Brabant, Belgium
    UZ Leuven
May 18, 2022

Parkinson Disease Trial in Leuven (11C-UCB-J PET-CT, 18F-PE2I PET-MR)

Completed
  • Parkinson Disease
  • 11C-UCB-J PET-CT
  • 18F-PE2I PET-MR
  • Leuven, Vlaams-Brabant, Belgium
    UZ Leuven
May 18, 2022

MDD Trial in Palo Alto, Stanford ([11C]UCB-J radiotracer, PET-MR)

Not yet recruiting
  • Major Depressive Disorder
  • [11C]UCB-J radiotracer
  • PET-MR
  • Palo Alto, California
  • +1 more
Sep 20, 2021

HIV Associated Neurocognitive Disorder, HIV Dementia, HIV Encephalitis Trial (SV2A PET, TSPO PET)

Not yet recruiting
  • HIV Associated Neurocognitive Disorder
  • +3 more
  • SV2A PET
  • TSPO PET
  • (no location specified)
Oct 16, 2022

Behavior, Health Trial in New Haven (Radiotracer)

Recruiting
  • Behavior, Health
  • New Haven, Connecticut
    Yale University PET Center
Jun 13, 2022

Schizophrenia Trial in Palo Alto, Stanford ([11C]UCB-J radiotracer, PET-MR)

Unknown status
  • Schizophrenia
  • [11C]UCB-J radiotracer
  • PET-MR
  • Palo Alto, California
  • +1 more
Nov 4, 2020

Precision Medicine in the Treatment of Epilepsy

Recruiting
  • Epilepsy
  • Copenhagen, Denmark
    Neurobiology Research Unit, Rigshospitalet
Jan 6, 2023

Healthy, Alzheimer Trial in Amsterdam, Groningen ([11C]-UCB-J)

Completed
  • Healthy
  • Alzheimer Disease
  • [11C]-UCB-J
  • Amsterdam, Netherlands
  • +2 more
Feb 19, 2020

Cannabis Use Disorder, Healthy Trial in New Haven ([11C]APP311)

Recruiting
  • Cannabis Use Disorder
  • Healthy
  • New Haven, Connecticut
    Yale University School of Medicine
Jul 20, 2022

Lung Cancer Trial in Montréal (Patients with a living donor, Patients with a UCB donor)

Active, not recruiting
  • Lung Cancer
  • Patients with a living donor
  • Patients with a UCB donor
  • Montréal, Quebec, Canada
    Hopital Sacre-Coeur
Feb 14, 2021

Microglia in the Pathogenesis of Progressive Multiple Sclerosis

Active, not recruiting
  • Multiple Sclerosis
    • Turku, Finland Proper, Finland
      Turku PET Centre
    Oct 12, 2022

    Schizophrenia, Smoking Cessation, Tobacco Use Trial in Stony Brook (Active deep transcranial magnetic stimulation (dTMS), Sham

    Not yet recruiting
    • Schizophrenia
    • +2 more
    • Active deep transcranial magnetic stimulation (dTMS)
    • Sham dTMS
    • Stony Brook, New York
      Stony Brook University
    Jan 27, 2023

    Infant, Extremely Premature, Erythrocyte Transfusion, Umbilical Cord Issue Trial (Red blood cell from umbilical cord blood, Red

    Not yet recruiting
    • Infant, Extremely Premature
    • +2 more
    • Red blood cell from umbilical cord blood
    • Red blood cell from adult donor
    • (no location specified)
    Nov 8, 2022

    MDD Trial in New York (Ketamine)

    Completed
    • Major Depressive Disorder
    • New York, New York
      New York State Psychiatric Institute/Columbia University
    May 31, 2022

    MDD, Anhedonia Trial in Saint Louis (Psilocybin)

    Withdrawn
    • Major Depressive Disorder
    • Anhedonia
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 26, 2023

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States

    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • +4 more
    • Single Umbilical Cord Blood Unit Transplant
    • +6 more
    • Birmingham, Alabama
    • +37 more
    Oct 13, 2021

    Basic Science Trial in Copenhagen (Psilocybine, Ketanserin)

    Recruiting
    • Basic Science
    • Copenhagen, Denmark
      Neurobiology Research Unit, Rigshospitalet
    Aug 11, 2022

    Depressive Disorder, Major, Treatment Outcome, Cognitive Dysfunction Trial in Copenhagen (Treatment Package for First-Episode

    Recruiting
    • Depressive Disorder, Major
    • +4 more
    • Treatment Package for First-Episode Depression
    • Copenhagen, Denmark
      Neurobiology Research Unit, Rigshospitalet
    Nov 12, 2022

    MDD, Depression Trial in Stockholm (Psilocybin, Niacin)

    Recruiting
    • Major Depressive Disorder
    • Depression
    • Stockholm, Sweden
      Northern Stockholm Spychiatry Clinic
    Apr 4, 2022